CHAPTER 1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2. EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. TOP WINNING STRATEGIES
3.4. PORTERS FIVE FORCES ANALYSIS
3.4.1. Bargaining power of suppliers
3.4.2. Bargaining power of buyers
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry
3.4.5. Threat of substitutes
3.5. MARKET SHARE ANALYSIS, 2015
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising prevalence of atrial fibrillation in geriatric population
3.6.1.2. Technological advancements
3.6.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment
3.6.2. Restraints
3.6.2.1. Dearth of skilled professionals
3.6.2.2. Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices
3.6.3. Opportunities
3.6.3.1. Rising awareness of atrial fibrillation
3.6.3.2. Opportunities in emerging countries
CHAPTER 4. ATRIAL FIBRILLATION MARKET, BY DEVICES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SURGICAL DEVICES
4.2.1.1. Key market trends
4.2.1.2. Key growth factors and opportunities
4.2.2. Market size and forecast
4.2.2.1. MAZE surgery
4.2.2.2.Catheter ablation
4.3. NON-SURGICAL DEVICES
4.3.1. Key market trends
4.3.1.2. Key growth factors and opportunities
4.3.2. Market size and forecast
4.3.2.1. Electric cardioversion
4.3.2.2. Mapping and recording systems
4.3.2.3. Cardiac monitors
4.3.2.4. Access devices
4.3.2.5. Left Atrial Appendage (LAA) and closure devices
4.3.2.6. Intracardiac echocardiography (ICE) systems
CHAPTER 5. ATRIAL FIBRILLATION MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. U.K. market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. ASIA PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.2. India market size and forecast
5.4.3.3. China market size and forecast
5.4.3.4. Australia market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.2. Argentina market size and forecast
5.5.3.3. Egypt market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast
CHAPTER 6. COMPANY PROFILES
6.1. ABBOTT LABORATORIES
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Business performance
6.1.5. Key strategic moves & developments
6.2. JOHNSON & JOHNSON
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Business performance
6.2.5. Key strategic moves & developments
6.3. ATRICURE, INC.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves & developments
6.4. MICROPORT SCIENTIFIC CORPORATION
6.4.1. Company overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Business Performance
6.4.5. Key strategic moves & developments
6.5. BOSTON SCIENTIFIC CORPORATION
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.6. ST. JUDE MEDICAL, INC.
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves & developments
6.7. MEDTRONIC PLC
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.8. BIOTRONIK SE & CO. KG
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Key strategic moves & developments
6.9. KONINKLIJKE PHILIPS N.V.
6.9.1. Company overview
6.9.2. Philips- SNAPSHOT
6.9.3. Operating business segments
6.9.4. Business performance
6.9.5. Key strategic moves and developments
6.10. SIEMENS AG
6.10.1. Company overview
6.10.2. Siemens Healthcare- SNAPSHOT
6.10.3. Operating business segments
6.10.4. Financial performance
6.10.5. Key strategic moves and developments